Page 3 - Oblte News Today

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) saw a significant growth in short interest in July. As of July 31st, there was short interest totalling 46,100 shares, a growth of 30.6% from the July 15th total of 35,300 shares. Based on an average daily trading volume, of 56,500 shares, the short-interest ratio is currently […]

Belite Bio (NASDAQ:BLTE – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.03), MarketWatch Earnings reports. Belite Bio Price Performance Shares of BLTE stock traded up $1.44 during trading hours on Thursday, reaching $24.50. The company’s stock had a […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) shares were up 7.9% on Friday . The company traded as high as $23.65 and last traded at $23.65. Approximately 28,900 shares changed hands during mid-day trading, a decline of 2% from the average daily volume of 29,641 shares. The stock had previously closed at $21.92. Analysts […]

Belite Bio (NASDAQ:BLTE – Get Free Report) will post its quarterly earnings results after the market closes on Wednesday, August 9th. Analysts expect Belite Bio to post earnings of ($0.23) per share for the quarter. Belite Bio (NASDAQ:BLTE – Get Free Report) last posted its earnings results on Wednesday, May 10th. The company reported ($0.33) […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) shares dropped 10.9% on Tuesday . The company traded as low as $20.66 and last traded at $20.70. Approximately 12,338 shares changed hands during trading, a decline of 58% from the average daily volume of 29,417 shares. The stock had previously closed at $23.22. Wall Street Analyst […]

Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) rose 9.3% during mid-day trading on Thursday . The company traded as high as $20.70 and last traded at $20.35. Approximately 49,558 shares changed hands during trading, an increase of 72% from the average daily volume of 28,859 shares. The stock had previously closed at […]

Cantor Fitzgerald initiated coverage on shares of Belite Bio (NASDAQ:BLTE – Free Report) in a report published on Friday morning, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $43.00 target price on the stock. BLTE has been the topic of several other reports. SVB Securities started coverage on shares of Belite Bio […]

Stock analysts at SVB Leerink started coverage on shares of Belite Bio (NASDAQ:BLTE – Get Free Report) in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage set an “outperform” rating and a $25.00 price target on the stock. SVB Leerink’s price target would indicate a potential upside of 34.26% […]

Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Benchmark in a research report issued on Tuesday, Benzinga reports. They currently have a $57.00 price objective on the stock. Benchmark’s price target would suggest a potential upside of 193.97% from the company’s previous close. Separately, HC Wainwright […]

Belite Bio (NASDAQ:BLTE – Get Free Report) and GeoVax Labs (NASDAQ:GOVX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership. Volatility & Risk Belite Bio has a […]